In this essay that originally appeared in Months to Years, writer Mal Schoen describes how he was diagnosed with colon cancer.
Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.
Online outreach and low-cost testing can encourage relatives of cancer patients to assess their own cancer risk through 'cascade' testing.
Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.
The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.
After her older sister died from cancer, 25-year-old Jacqueline Genovese took over care for her children, a 2-year-old and a 4-year-old.
A profile by The Scientist of Lucy Shapiro, PhD, highlights her career and the passions that guided her groundbreaking scientific research.
Stanford scientists have discovered the signaling pathway responsible for making sure all DNA is replicated before cell division can occur.
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.
Stanford study finds no evidence of increased thyroid cancer risk in commercial airline crew, despite their increased exposure to cosmic ionizing radiation.
People who develop abnormal numbers of skin cancers called basal cell carcinomas may be at increased risk of other, unrelated internal cancers.
Stanford's Manali Patel found higher satisfaction and lower costs for advanced cancer patients who spoke with a nonclinical worker about care preferences.
A small magnetic wire that attracts nanoparticles engineered to stick to tumor cells may stand to detect cancer earlier.
The American Cancer Society joins forces with National Cancer Institute-designated cancer centers to promote the HPV vaccine and eliminate cervical cancer.
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
Denise Wong had survived breast cancer treatment at 27. Ten years later, she and her husband wanted to have a child. Her treatment had made that unlikely, but her fertility team at Stanford found a way.